In a report released today, Stephen Willey from Stifel Nicolaus maintained a Hold rating on Bolt Biotherapeutics (BOLT – Research Report), with a price target of $1.50. The company’s shares ...

Bolt Biotherapeutics (BOLT) announced that the target of their worldwide co-development collaboration with Toray Industries is Caprin-1, a cancer target discovered by Toray. The collaborators are ...

The original soundtrack to his acclaimed Michael Gracey-directed biopic, Better Man outsells the rest of the Top 5 combined to stand proud at the summit of the Official Albums Chart; now drawing ...

Kendrick Lamar has taken the lead for his first UK Number 1 single. Not Like Us charges up to Number 1 midweek, following its Top 10 re-entry last week, following Kendrick’s acclaimed Super Bowl ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After the best two-year stretch for the S&P 500 (^GSPC) since the late 1990s, few on Wall Street are calling for an end to the bull market run, and this optimism serves as the key throughline in ...

over 6000 assets (including all Forex pairs, Cryptocurrencies, Commodities, Indices and US stocks) unique interbank rates extensive historic data the option to save your configuration Here below ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Albert Edwards, the famously bearish strategist at the French investment bank Societe Generale, has seen his share of euphoric episodes in financial markets. He called the dot-com bubble in the US ...

The Tampa Bay Buccaneers were dealt a sudden blow last week when Liam Coen went from deciding to sign a contract extension to remain the team's offensive coordinator to accepting the Jacksonville ...